Tag Archives: Genesis Healthcare

Cantor Fitzgerald Keeps Their Buy Rating on Genesis Healthcare (GEN)

Cantor Fitzgerald analyst Joseph France maintained a Buy rating on Genesis Healthcare (GEN – Research Report) today and set a price target of $7. The company’s shares opened today at $1.68. France noted: “We rate GEN $7 price target. We

Cantor Fitzgerald Maintains a Buy Rating on Genesis Healthcare (GEN)

In a report released today, Joseph France from Cantor Fitzgerald maintained a Buy rating on Genesis Healthcare (NYSE: GEN), with a price target of $7. The company’s shares closed yesterday at $1.28. France noted: “We rate GEN $7 price target.

Cantor Fitzgerald Sticks to Their Buy Rating for Genesis Healthcare (GEN)

Cantor Fitzgerald analyst Joseph France maintained a Buy rating on Genesis Healthcare (NYSE: GEN) today and set a price target of $7. The company’s shares opened today at $1.52. France observed: “We rate GEN $7 price target. We believe that

The SVP & Corp Contr of Genesis Healthcare (NYSE: GEN) is Selling Shares

Today, the SVP & Corp Contr of Genesis Healthcare (NYSE: GEN), Stephen Scott Young, sold shares of GEN for $8,356. In addition to Stephen Scott Young, 8 other GEN executives reported Sell trades in the last month. See today’s analyst

Stifel Nicolaus Reiterates a Hold Rating on Genesis Healthcare

Stifel Nicolaus analyst Chad Vanacore reiterated a Hold rating on Genesis Healthcare (NYSE: GEN) today and set a price target of $2. The company’s shares opened today at $1.48. According to TipRanks.com, Vanacore is a 1-star analyst with an average

Genesis Healthcare Gets a Hold Rating from Stephens

In a report released today, Dana Hambly from Stephens reiterated a Hold rating on Genesis Healthcare (NYSE: GEN), with a price target of $2. The company’s shares opened today at $1.53. According to TipRanks.com, Hambly is a 3-star analyst with